These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7816784)

  • 1. Epidemiological and financial aspects of the use of non-steroidal anti-inflammatory analgesics.
    Paakkari H
    Pharmacol Toxicol; 1994; 75 Suppl 2():56-9. PubMed ID: 7816784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental cost-effectiveness analysis comparing rofecoxib with nonselective NSAIDs in osteoarthritis: Ontario Ministry of Health perspective.
    Marshall JK; Pellissier JM; Attard CL; Kong SX; Marentette MA
    Pharmacoeconomics; 2001; 19(10):1039-49. PubMed ID: 11735672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding.
    Edelson JT; Tosteson AN; Sax P
    JAMA; 1990 Jul; 264(1):41-7. PubMed ID: 2113103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis.
    Jobanputra P; Nuki G
    Curr Opin Rheumatol; 1994 Jul; 6(4):433-9. PubMed ID: 8068516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of initial NSAID choice and patient risk factors in the prevention of NSAID gastropathy: a decision analysis.
    Fendrick AM; Bandekar RR; Chernew ME; Scheiman JM
    Arthritis Rheum; 2002 Feb; 47(1):36-43. PubMed ID: 11932876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of nonsteroidal anti-inflammatory drug-associated gastrointestinal symptoms and ulcer complications.
    Peura DA
    Am J Med; 2004 Sep; 117 Suppl 5A():63S-71S. PubMed ID: 15478855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoeconomics of nonsteroidal anti-inflammatory drugs (NSAIDs).
    Wynne HA; Campbell M
    Pharmacoeconomics; 1993 Feb; 3(2):107-23. PubMed ID: 10146960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons.
    Smalley WE; Ray WA; Daugherty JR; Griffin MR
    Am J Epidemiol; 1995 Mar; 141(6):539-45. PubMed ID: 7900721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arthritis treatment in Hong Kong--cost analysis of celecoxib versus conventional NSAIDS, with or without gastroprotective agents.
    You JH; Lee KK; Chan TY; Lau WH; Chan FK
    Aliment Pharmacol Ther; 2002 Dec; 16(12):2089-96. PubMed ID: 12452942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Educational program for physicians to reduce use of non-steroidal anti-inflammatory drugs among community-dwelling elderly persons: a randomized controlled trial.
    Ray WA; Stein CM; Byrd V; Shorr R; Pichert JW; Gideon P; Arnold K; Brandt KD; Pincus T; Griffin MR
    Med Care; 2001 May; 39(5):425-35. PubMed ID: 11317091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury.
    Griffin MR
    Am J Med; 1998 Mar; 104(3A):23S-29S; discussion 41S-42S. PubMed ID: 9572317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keeping patients with arthritis out of the hospital.
    Spiegel M
    Manag Care Interface; 1998 Jun; 11(6):81-5. PubMed ID: 10181565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis.
    El-Serag HB; Graham DY; Richardson P; Inadomi JM
    Arch Intern Med; 2002 Oct; 162(18):2105-10. PubMed ID: 12374519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility analysis of duloxetine in osteoarthritis: a US private payer perspective.
    Wielage RC; Bansal M; Andrews JS; Klein RW; Happich M
    Appl Health Econ Health Policy; 2013 Jun; 11(3):219-36. PubMed ID: 23616247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-conscious prescribing of nonsteroidal anti-inflammatory drugs for adults with arthritis. A review and suggestions.
    Greene JM; Winickoff RN
    Arch Intern Med; 1992 Oct; 152(10):1995-2002. PubMed ID: 1417372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of nonsteroidal anti-inflammatory drugs.
    Tenenbaum J
    Can J Gastroenterol; 1999 Mar; 13(2):119-22. PubMed ID: 10203429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risks and costs of upper gastrointestinal disease attributable to NSAIDs.
    Smalley WE; Griffin MR
    Gastroenterol Clin North Am; 1996 Jun; 25(2):373-96. PubMed ID: 9229579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diclofenac/misoprostol. A review of its pharmacology and therapeutic efficacy in painful inflammatory conditions.
    Davis R; Yarker YE; Goa KL
    Drugs Aging; 1995 Nov; 7(5):372-93. PubMed ID: 8573992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budget impact modeling for a single-tablet formulation of ibuprofen and famotidine for prevention of upper gastrointestinal ulcers in patients with osteoarthritis and/or rheumatoid arthritis.
    Kuan R; Holt RJ; Johnson KE; Kent JD; Peura DA; Malone D
    Clin Ther; 2013 Mar; 35(3):321-32. PubMed ID: 23497762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.